Clinical Trial

Natriuresis-guided Depletion After Cardiac Surgery

Study acronym: EASY-CS
Recruiting
View on ClinicalTrials.gov →
Summary
Fluid overload (FO) is a common complication after cardiac surgery, associated with increased morbidity and mortality. Loop diuretics, especially furosemide, are routinely used to manage FO, but their use is often empirical. Recent data suggest that natriuresis-guided furosemide titration using point-of-care urinary sodium sensors (LAQUAtwin NA-11, Horiba) may improve the efficiency and safety of fluid removal, but no randomized trial has yet evaluated this approach in postoperative cardiac surgery patients Our goal is to assess the clinical impact, safety, and feasibility of a natriuresis-guided furosemide protocol after cardiac surgery requiring cardiopulmonary bypass.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-12.
Status change: Not Yet Recruiting → Recruiting 2026-01-19
Trial Details
NCT Number NCT07077772
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Conditions Cardiac Surgery, Diuresis, Congestion, Venous, Sodium Depletion, Fluid Over-load
Enrollment 102 participants
Start Date 2025-06-25
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-21